DiscoverThe Psychedelic Invest PodcastDarryl Hudson is Developing Psilocybin-Based Therapeutics
Darryl Hudson is Developing Psilocybin-Based Therapeutics

Darryl Hudson is Developing Psilocybin-Based Therapeutics

Update: 2023-11-09
Share

Description

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Darryl Hudson, the Co-Founder and CIO of GoodCap Pharmaceuticals.



Darryl Hudson is a PhD in Molecular Biology and Genetics and is active in the Hemp, Cannabis and Psychedelic Drug Development Industries.



GoodCap Pharmaceuticals Inc. (goodcap.com) is a leading Canadian drug development company devoted to harnessing and applying the physical and mental health benefits of mushrooms and mushroom-derived compounds. GoodCap is a leader in formulation, research and development of psilocybin-based therapeutic products and is dedicated to discovering natural therapies for inflammatory disorders and mental health conditions.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Darryl Hudson is Developing Psilocybin-Based Therapeutics

Darryl Hudson is Developing Psilocybin-Based Therapeutics

PsychedelicInvest.com